Pharmacokinetics and pharmacodynamics of fluticasone propionate and salmeterol delivered as a combination dry powder from a capsule-based inhaler and a multidose inhaler in asthma and COPD patients. [electronic resource]
Producer: 20150413Description: 279-89 p. digitalISSN:- 1941-2703
- Administration, Inhalation
- Adrenergic beta-2 Receptor Agonists -- administration & dosage
- Adult
- Aerosols
- Aged
- Albuterol -- administration & dosage
- Androstadienes -- administration & dosage
- Area Under Curve
- Asthma -- diagnosis
- Biological Availability
- Bronchodilator Agents -- administration & dosage
- Double-Blind Method
- Drug Administration Schedule
- Drug Combinations
- Dry Powder Inhalers
- Equipment Design
- Female
- Fluticasone-Salmeterol Drug Combination
- Humans
- Lung -- drug effects
- Male
- Middle Aged
- New South Wales
- New Zealand
- Particle Size
- Powders
- Pulmonary Disease, Chronic Obstructive -- diagnosis
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.